In Setback for AstraZeneca, E.U. Court Rules for Generics

Law360, New York (October 17, 2003, 12:00 AM EDT) -- In a setback for large pharmaceutical companies, the European Court of Justice on Thursday backed Generics U.K. Ltd.'s bid to market older, capsule versions of AstraZeneca's Losec heartburn drug under a fast-track procedure, the Wall Street Journal reported Friday.

In their ruling, the judges wrote that encouraging the sale of older but safe versions of drugs avoids "the repetition of tests on humans or animals" and "save the time and expense needed to gather the results" of carrying out new tests, according to the Journal....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.